JAK2 and osteosarcoma: The osteosarcoma, proliferation, and immune escape through the JAK2–STAT3–PD–L1-signaling axis can all be inhibited by the liposomal form of QUE by inhibiting JAK2 through the JH2 domain in a non-covalent way [76].